DCK Produkte
(Deoxycytidine Kinase (DCK))
Kategorien
antibodies-online.com steht für hochwertige Forschungsprodukte. Suchen, finden und bestellen Sie Tools mit umfangreichen Validierungsdaten, Bildern, Referenzen. Unser wissenschaftlicher Kundenservice steht Ihnen jederzeit zur Verfügung, wenn Sie Fragen zur Auswahl oder Anwendung unserer Produkte haben.
Ausgewählte DCK Kategorien
DCK Antikörper
High quality antibodies with extensive validation data.
DCK ELISA Kits
Reliable ELISA kits for a wide range of species.
DCK Proteine
Proteins for various applications incl. WB, ELISA, IF etc.
Empfohlene DCK Antikörper
- (6)
- (8)
- (7)
Empfohlene DCK ELISA Kits
- (1)
- (1)
Empfohlene DCK Proteine
- (1)
- (1)
Neueste Publikationen zu unseren DCK Produkten
: "Bortezomib prevents cytarabine resistance in MCL, which is characterized by down-regulation of dCK and up-regulation of SPIB resulting in high NF-κB activity." in: BMC cancer, Vol. 18, Issue 1, pp. 466, (2018) (PubMed).: "Prognostic effect of hENT1, dCK and HuR expression by morphological type in periampullary adenocarcinoma, including pancreatic cancer." in: Acta oncologica (Stockholm, Sweden), Vol. 55, Issue 3, pp. 286-96, (2016) (PubMed).
: "The effects of forodesine in murine and human multiple myeloma cells." in: Advances in hematology, Vol. 2010, pp. 131895, (2010) (PubMed).
: "Population-specific genetic variants important in susceptibility to cytarabine arabinoside cytotoxicity." in: Blood, Vol. 113, Issue 10, pp. 2145-53, (2009) (PubMed).
: "The role of HuR in gemcitabine efficacy in pancreatic cancer: HuR Up-regulates the expression of the gemcitabine metabolizing enzyme deoxycytidine kinase." in: Cancer research, Vol. 69, Issue 11, pp. 4567-72, (2009) (PubMed).
: "Laser microdissection and primary cell cultures improve pharmacogenetic analysis in pancreatic adenocarcinoma." in: Laboratory investigation; a journal of technical methods and pathology, Vol. 88, Issue 7, pp. 773-84, (2008) (PubMed).
: "Pharmacogenetics of deoxycytidine kinase: identification and characterization of novel genetic variants." in: The Journal of pharmacology and experimental therapeutics, Vol. 323, Issue 3, pp. 935-45, (2007) (PubMed).
: "Molecular basis of 2',3'-dideoxycytidine-induced drug resistance in human cells." in: Molecular and cellular biochemistry, Vol. 231, Issue 1-2, pp. 173-7, (2002) (PubMed).
Synonyme und alternative Namen zu DCK
deoxycytidine kinase (DCK), deoxycytidine kinase (dck), deoxycytidine kinase, gene 2 L homeolog (dck.2.L), deoxycytidine kinase, gene 2 (dck.2), deoxycytidine kinase (Dck), Deoxycytidine kinase (FPV059), Deoxycytidine kinase (FPV151), deoxycytidine kinase, gene 1 L homeolog (dck.1.L), dck, DCK, dck1, wu:fc15f06, zgc:101771Bezeichner auf Proteinebene für DCK
- deoxynucleoside kinase
- Deoxycytidine kinase
- deoxycytidine kinase
- deoxycytidine kinase 1
- deoxyribonucleoside kinase